Receptors And Ion Channels Flashcards

1
Q

What is the rINN name for the following drugs

a) butoxamine
b) clorgyline
c) amphetamine

A

a) butaxamine
b) clorgiline
c) amfetamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is 5-HT

A

5-hydroxytryptamine (serotonin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Are steroid receptors membrane bound or cytosolic

A

They are cytosolic proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give the five forces involved in the structure of a receptor in diminishing order of strength

A

Covalent bonds

Ionic bonds

Hydrogen bonds

Van der Waals Forces

Hydrophobic forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How are large ligands believed to bind to receptors

A

Through a zipper interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define agonist in terms of a receptor

A

An agonist binds to receptors and produces a response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the approximate relationship between the size of the response and the concentration of agonist

What about when the response is plotted against the logarithm of the agonist concentration

A

Hyperbolic

Sigmoidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the amount of a receptor that is bound by a given concentration of a drug governed by?

A

The affinity of the drug for the binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is efficacy

A

The relationship between the amount of receptor occupied by a drug and the size of the response produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

True or false

An agonist has both affinity and efficacy

A

True

as they both binds to and activates a receptor to produce a response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

True or false

Both antagonists and agonists display efficacy

A

False

both display affinity as antagonists bind but elicit no response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is efficacy usually measured

What does this allow calculations of

A

On a log graph

EC50 - A measure of potency for agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is EC 50

A

The concentration of the agonist that causes 50% of the maximum response

The response does NOT indicate the concentration of agonist occupying half of the receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is potency

A

The concentration causing a particular magnitude of response (e.g. EC 50) - not to the size of the maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens to the log concentration/response curve for an agonist in the presence of a competitive antagonist

A

It is shifted to the right in a parallel fashion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Can a maximal response be obtained if the agonist is in the presence of a competitive antagonist

Therefore what is another name of competitive antagonism

A

Yes, if enough agonist is added then the same maximal response is obtained

Surmountable antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Does the addition of a competitive antagonist increase or decrease the EC 50

A

Increase

Maximal response remains the same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is a structure activity series

A

A sequence of experiments to determine the relative potency of a group of structurally related compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What can be used to aid receptor classification

Give an example

A

In the case of ACh, two structure activity series can be seen and these help demonstrate the existence of two types of receptor, nicotinic and muscarinic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Why can drugs with the same chemical formula offer different potencies

What does this demonstrate

A

Stereoisomers act differently

The complementarity of the interaction between drug and receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is acetyl-β- methylcholine

What does its stereoisomer do

What does this mean for the racemate of acetyl-β-methylcholine?

A

Cholinergic agonist

Isomer has no affinity

Effectively reduces the concentration of the active isomer by half

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does isoprenaline do

What is the effect of its stereoisomer

What happens if you increase concentrations of the racemate

A

β- adrenoceptor agonist

Inactive isomer has affinity but no efficacy so acts as an antagonist

Simultaneously increases [agonist] and [antagonist]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the forward and backward reactions of the following know as:

D+R↔️DR

What does the rate of each equal?

A

Forward: K+1; rate =K+1[D][R]
Backwards: K-1; rate = K-1[DR]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the notation for the affinity constant of drug D

A

Ka (=k+1/k-1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
The higher the Ka, the ____ the affinity of D for R
Higher
26
What is Kd How to work out Kd
The dissociation constant 1/Kd
27
What are the units of Ka What about for Kd
M-1 or L/mol M or mol/L
28
Describe D+R↔️DR in terms of α, where α is a fraction of receptors that combine with drug D Therefore, what does Ka= in terms of α Thus, what does it mean if α= 0.5
D + (1-α)↔️DR α ————- [D](1-α) [D]= 1/Ka = Kd
29
Describe α in terms of Ka and [D] α=?
[D] Ka ————- 1+[D]Ka
30
When α=0.5, [D]=1/Ka=Kd. What does this mean in reality?
The affinity constant is the reciprocal of the drug constant that produces 50% occupancy of the receptors
31
The affinity constant is the reciprocal of the drug constant that produces 50% occupancy of the receptors. This is usually the concentration of an agonist that causes the half maximal response - true or false?
False
32
How can you measure the binding of a drug to its receptor directly
Using radioligand binding
33
What does the binding of a radio ligand consist of
Saturable component (specific binding to receptors) and amazing effectively linear non-saturable component (non - specific binding to non receptor material)
34
How is specific and non specific binding of radio ligands affected in the presence of a large excess of unlabelled ligand
Specific- almost completely abolished Non- specific- almost unaffected
35
How can specific binding of radioligands be calculated
The difference between total binding and non specific binding in the presence of a large excess of non labelled ligands
36
Two of those Specific binding sites always represent functional receptors
False Conclusions from binding experiments must be supported by data about the functional behaviour of the putative receptor
37
How does the graph of specific binding and non specific binding differ on a chart of [radioligand] vs bound radioligand
Specific and total: rectangular hyperbola Non specific: linear
38
Describe α in terms of B (specific binding at the radiolabelled concentration [D]) and Bmax (maximal specific binding)
α= B/Bmax
39
Describe the equation for the double reciprocal graph of the following equation α= B/Bmax= [D]Ka/1+[D]Ka How to calculate Ka and Bmax
1/B=1/[D] x 1/BmaxKa + 1/Bmax ``` 1/Bmax= y intercept -Ka= x intercept ```
40
What are the 2 axes for the Scatchard plot How do you find out Ka and Bmax? What does [D] refer to
B(x) vs B/[D] (y) Gradient = -Ka X intercept= Bmax Free drug (NOT total concentration added)
41
Why is the Scatchard plot useful
Helps demonstrate situations where there maybe more than one binding site on a receptor It can show the different affinities of each site
42
Can the different binding sites on a receptor affect the affinities of different binding sites
Yes - oxygen binding to haemoglobin - positive cooperativity
43
What graph is cooperativity seen in
A plot of frequency of channel opening vs agonist concentration It is sigmoidal and NOT hyperbolic
44
What is the Hill plot
The equation relating binding to drug concentration can be modified to generate the Hill plot which reveals cooperativity
45
What are the axes of the Hill plot
``` x= log[D] y= Log B/(Bmax-B) ```
46
What indicated positive and negative cooperativity on a Hill plot
nH >1 is positive | nH <1 is negative
47
What does the nH =1 mean In this condition, what does X=, if y=0
1:1 binding between drug and active site No interaction between binding sites LogKd
48
Describe a Hill plot line where there are multiple non interacting binding sites
nH <1 but line will not be straighten
49
When a fixed concentration of radioligand is used to describe the shape of the graph of ligand binding against log concentration of competing unlabelled drug What do we need to know for this
Sigmoid The concentration of unlabelled drug that displaces 50% of the specifically bound radio ligand
50
What is IC50?
The concentration of unlabelled drug that displaces 50% of the specifically bound radio ligand
51
What is the equation for the occupancy of receptors by unlabelled ligand α When [U]=IC50, What does α=?
[U] x KU ———————————- 1+([U]xKU)+([L] x KL) Where KU and KL are affinity constants for the binding of labelled and unlabelled drugs α=0.5
52
Give an equation for KU, when [U]=IC50 KU=...
1+[L]KL ———— IC50
53
Is there a direct linear relationship between affinity and efficacy
This was thought to be true up until the 1960’s when it was believed that Kd=EC50 This was proved to be incorrect through experiments with Benzilylcholine mustard
54
What did experiments with BzCh reveal Describe associated efficacy/ affinity graphs
The concept of ‘spare’ receptors Affinity does not equal efficacy Efficacy results from significant amplification of the response so is always left shifted from affinity Both are sigmoidal
55
What does BzCh mustard (an antagonist) do to its receptor What would be expected if the agonist response generated were directly proportional to receptor occupancy? What actually happens?
Irreversibly alkylates the muscarinic receptor As progressive alkylation occurs thete should be a decrease in maximum response from the agonist with no change in apparent affinity of remaining receptors With ACh, on the guinea pig ileum, only a fraction of the receptors need to be bound to to produce a maximal response
56
What happens as the amount of BzCh increases with the amount of ACh? How can we estimate which percentage of receptors are spare?
At first maximal response is still attainable as BzCh is only affecting spare receptors Once BzCh fills all spare receptors, maximal response is still just possible Any extra BzCh results in a fall off of the maximal response By measuring dose ratio at the point where maximal response is just attainable
57
What is the dose ratio for ACh in the guinea pig ileum What does this mean
100 99% of the receptors are spare
58
Why does it make sense for a receptor to have a low affinity for an agonist What does this mean for the number of spare receptors
So the offset rate is high and the response is terminated quickly The existence of spare receptors here increases the sensitivity of the tissue to the agonist
59
How can you determine the affinity constant of an agonist from a log conc/ response curve
It is not possible because response is not directly proportional to receptor occupancy
60
What does the dose ratio determining method assume Why do we know this
Only have equal responses are produced by equal agonist Antagonist affinities determined in this way are the same as those determined by direct binding
61
What is the effect of adding a partial agonist alongside a full agonist Why does this happen
Partial agonist acts like a competitive antagonist By occupying receptors relatively ineffectually and preventing the full agonist from binding
62
What does α= for drug D and antagonist A
α= [D]K1 ————————- 1+[D]K1 +[A]K2
63
Give an example of drugs that don’t need to bind to receptors to have an effect
Ant acids - only change pH Some diuretics only exert osmotic pressure
64
What is the shape of a graph of bound receptors vs [D]
Hyperbolic
65
What kind of bond is formed by an irreversible inhibitor
Covalent
66
Which kind of inhibitor reduces Vmax
Irreversible
67
Why can irreversible inhibitors still be surmountable
They may only block spare receptors so enough receptors are still present for a full response to occur
68
Why do partial agonists act as inhibitors
Partial agonists require all receptors so its weaker effect blocks the more powerful effect that could be elicited by the full agonist
69
What does the drug ratio (R)-1 of an antagonist (B) equal What kind of antagonist is this for
R-1=[B] x Kb Reversible antagonist
70
What are the agonist, partial agonist and antagonist for μ-opioid receptors
``` Morphine = full agonist Buprenorphine = partial agonist Naloxone= competitive antagonist ```
71
Define agonist
A substance that initiates a physiological response when combined with a receptor
72
Define antagonist
A substance which interferes with/ inhibits the physiological action of another
73
Define competitive antagonist
Bonds to the same site as the agonist but does not activate it, thus blocking the agonist’s action
74
Define partial agonist
A substance that binds to and activates a given receptor, but only has partial efficacy at the receptor relative to a full agonist
75
Define inverse agonist
A drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist
76
Define biased agonism
AKA functional selectivity Ligand dependant selectivity for certain signal transduction pathways relative to a reference ligand at the same receptor
77
V1=
C2 x V2 —————- C1
78
Should there be air in the intra-abdominal cavity? What should you be thinking
No This suggests a perforation PEPTIC ULCERS
79
What is the dose ratio
[D2] —— = 1+[A]K2 [D1]
80
How does K1 affect the dose ratio
Dose ratio is independent of K1
81
What is the problem with dose ratio
We only have a single concentration of the antagonist to calculate affinity which is unsatisfactory experimentally Normally multiple doses are used to compete with the agonist allowing a Schild regression to be generated
82
What are the axes of the Schild regression What can this be used to find
Log[antagonist] y= Log[dose ratio-1] X intercept = affinity of the competitive antagonist (if the slope is of unity)
83
What are the 5 drug receptor families Give an example for each
1. Intracellular (NO or steroid receptors) 2. Directly operated ion channels (nicotinic ACh receptor) 3. Intrinsic enzyme activity receptors (eg RTK) 4. Those linked to enzymes (eg EPO) 5. GPCRs (eg β adrenoceptor or muscarinic ACh receptor)
84
Which 2 groups can intracellular receptors be divided into
Those with enzymatic activity (eg soluble guanylyl cyclase Those that bind to lipid soluble agonists eg steroids
85
Describe the activity of soluble guanylyl cyclase
NO is released from endothelial cells to cross the PM and interact with soluble guanylyl cyclase, which converts GTP to cGMP cGMP activates PKG, promoting smooth muscle relaxation
86
How is cGMP broken down How can this be inhibited
By cGMP phosphodiesterase Sildenafil citrate
87
What are the 3 domains of the steroid receptors
Lipid binding domain DNA binding domain Transcription activating domain
88
Where do steroid receptors usually reside Name an exception
In the cytoplasm but trans locates to the nucleus upon activation by ligand Oestrogen receptor - May be located in the nucleus even in the absence of a ligand
89
Describe the time period of steroid activity Which other group of hormones work in this way
Effects typically appear after a lag and may persist for hours or days Thyroid hormones
90
What kind of communication do ligand gated ion channels allow
Fast communication between cells
91
What is the best characterised ligand gated ion channel How has it been studied
the nicotinic ACh receptor Using the patch clamp technique
92
Describe quantitively the behaviour of a nicotinic ACh receptor (nAChR)
In response to ACh, the channel opens for about 1ms, allowing passage of ~10,000 Na+ ions Frequency of channel opening increases with increasing [agonist]
93
What is the Hill coefficient for nAChR
2
94
Describe the structure of the nAChR
Pentameter 2α, β, γ, and δ α and its neighbour bind ACh and Both must be occupied to elicit a response Each subunit has 4 hydrophobic stretches (M1-4) M2 May form an α helix within the membrane and the 5 M2 regions apparently line the pore of the channel
95
Is GC soluble or membrane bound
Both Membrane bound GC is similar to soluble guanylyl cyclase function except the receptor is bound to the membrane
96
Describe the structure of a membrane bound GC
Receptor is a dimer and binds molecules such as ANP
97
How does ANP bind to membrane GC
Binds to the extracellular face of the receptor dimer which activates the guanylyl cyclase domain on the intracellular face
98
What are RSKs
Receptor serine/ threonine kinases Transmembrane proteins of the plasma membrane and Are characterised by extracellular ligand binding domains and cytoplasmic kinase domains
99
What superfamily do RSKs belong to Thus what roles are they involved in
Transforming growth factor β (TGF-β) Physiological and pathological processes of the metres are in life including early embryogenesis, atherosclerosis and cancer
100
What are the 2 sy types of RSKs
Type 1 and 2 Based on primary amino acid sequence - upon ligand binding a heteromeric complex of both types is formed and Type 2 phosphorylates and activates Type 1 Type 1 then plays a role in downstream signalling
101
What do activated RSKs recruit
SMADs - when SMAD4 is recruited, a complex of activated SMADs and SMAD4 translocate to the nucleus and influence gene expression for cell proliferation
102
What does every RTK have Name 2 molecules that bind to them What do all RTK do at some point
An intracellular catalytic domain and an extracellular regulatory domain Insulin EGF PDGF Activate the G protein Ras
103
How many polypeptide chains do the receptors for the following contain Insulin EGF
Insulin: Contains two different peptide chains linked as a dimer (βα-αβ) EGF: a single polypeptide chain
104
Does dimerisation come before or after autophosphorylation in EGF RTK?
Dimerisation precedes auto phosphorylation
105
Are RTK responses rapid
They can be fast or delayed
106
Why are RTKs of interest to virologists
Several. Viral oncogenes encode mutated forms of either receptors or ligands Eg v-erb encodes a truncated, constitutively active EGF receptor V-sis encodes a PDGF chain
107
How do RTKs and RSKs differ from receptors linked to soluble kinases
In receptors linked to soluble kinases, the kinase domain is encoded on separate genes from the transmembrane receptor but then associate together
108
Give an example of receptors linked to soluble kinases
The EPO receptor Signalling is facilitated by the JAK-STAT pathways - inducers of TFs Disrupted JAK-STAT signalling May lead to many different disorders
109
How many subunits do receptors of GPCRs have
1 of a size or 40-50kDa
110
What do all GPCRs have
7 transmembrane α helices (N extracellular, c intracellular)
111
Where is the GPCR’s ligand binding site How does the receptor interact with the G protein
Usually buried within the transmembrane helices Via the 3rd intracellular loop and C terminal tail
112
How does cAMP control cell function
Through PKA
113
How may GPCRs affect AC
Activate (β1-AR) - Gs or inhibit (α2 -AR) - Gi
114
Describe the structure of G proteins Where can the difference between Gi and Gs be found
Heterotrimers, consisting of an α subunit, a β subunit and a γ subunit In the α subunit which binds and hydrolyses GTP
115
What happens to a G protein when a GPCR is occupied by an agonist
The receptor forms a transient complex with Gs, which is occupied by GDP GDP-GTP exchange promotes Gs release and causes a reduction in binding affinity of agonist to receptor βγ is also released, while αs forms an active enzyme complex with AC
116
How does G protein activity end
Agonist activates GTPase activity terminates the active state of αs and βγ recouples
117
How does Cholera toxin act
Causes ADP-ribosylation of αs This inhibits GTPase activity and causes sustained activity of AC
118
How can the βγ complex be inhibitory
Through the mopping up of free αs Can also have effects on AC (independent of αs)
119
How does pertussis toxin work
ADP-ribosylation of αi and prevents activation of Gi in response to receptor stimulation
120
Name a group of organists that stimulate the metabolism of inositol phospholipids in the plasma membrane
ACh (at mAChR) Noradrenaline ( at α1 ARs) Substance P
121
Which G proteins activate phospholipase C
G11 and Gq
122
What are the cleavage products of PIP2 and what do they Do
DAG - Stimulate membrane-bound PKC, which modifies properties of various proteins such as ion channels by phosphorylation IP3- Causes the release of calcium from the endoplasmic reticulum
123
How is IP3 metabolised
By phosphorylation to IP4 or by dephosphorylation successively to inositol
124
Why is lithium used to treat bipolar disorder
That’s the uncompetitively inhibits the phosphatase that is responsible for converting IP1 to inositol thereby blocking recycling of inositol
125
Overall what does it mean if a receptor is desensitised
Transduction mechanism is uncoupled
126
What are the three processes involved in desensitisation
Uncoupling Sequestration Down-regulation
127
Describe the uncoupling part of desensitisation
This is uncoupling of the receptor from its G-protein Takes place over the course of seconds two minutes and is due to phosphorylation events at the receptor
128
Describe the sequestration part of desensitisation
Receptors are removed from the plasma membrane by endocytosis and transferred to vesicles in the cytoplasm This takes place over minutes The receptors can be shuffled back to the plasma membrane but can also be destroyed in lysosomes this destruction can be elevated in the down regulation stage
129
Describe the time regulation stage of desensitisation
Takes place over minutes two hours The number of receptors available to be shuttled to and from the plasma membrane is reduced this is possibly due to reduced receptor synthesis by effect of PKA on mRNA stability
130
Can sequestration or down-regulation in desensitisation take place without uncoupling
No
131
What are the different types of desensitisation
Homologous and Heterologous
132
Described a homologous desensitisation using the example of the β2adrenoreceptor
The adrenoreceptor can upon ligand binding be phosphorylated by GRK (usually GRK2/3) GRK phosphorylates sites at the end of the C terminal membrane which increases the infinity of the beta 2 adrenoreceptor for another protein called β arrestin The binding of β arrestin to receptor uncouples the receptor from the α-subunit of Gs thus producing desensitisation
133
How many GRKs are there
GPCR kinases - 7 types with 2,3,5 being the most important
134
Why is it called homologous desensitisation
GRKS only work on agonist occupied receptors so does not affect any other receptors that might be present
135
How does heterologous desensitisation work
Stimulation of β2 ARs increases cAMP, stimulating PKA If the receptor is disproportionately stimulated, there will be a large rise in PKA activity, which is able to phosphorylate site on the β2- receptor itself This phosphorylation uncouples the receptor from the α-subunit of Gs, thus rendering it ineffective
136
Where does high levels of PKA phosphorylate the β2 receptor
At site on the third cytoplasmic loop and the first part of the C terminal domain
137
Why is heterologous desensitisation of adrenoreceptors considered heterologous
PKA can also phosphorylate receptors with similar amino acid sequences so other receptors than in the β2 ARs can be desensitised without having first been stimulated by a ligand
138
Can one GPC are couple to more than one G protein
Yes and can also be activated by multiple agonists
139
What is the bias of an agonist
The degree by which the agonist activates different pathways
140
What can β arrestin do for GPCRs
Recruitment of β arrestin blocks the G protein interaction but can now enable additional G protein independent signalling events
141
Give an example of a drug that uses GPCR bias
Oliceridine TRV130 μ-opioid receptor biased agonist that elicits robust G protein signalling, with potency and efficacy to morphine but with less β arrestin 2 recruitment and receptor internalisation thus having reduced adverse effects compared to morphine